Harvard Bioscience, Inc. (HBIO) Ownership

$0.59

south_east
-$0 (-0.31%)
Day's range
$0.57
Day's range
$0.61

Harvard Bioscience, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 02/07/2025 2.98 M $6.29 M   2.24% 6.84%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 02/14/2025 2.76 M $5.81 M   -0.62% 6.32%
HARVEY PARTNERS, LLC 02/14/2025 2.68 M $5.66 M   -1.18% 6.15%
AMH EQUITY LTD 02/05/2025 2.50 M $5.28 M   4.65% 5.73%
VANGUARD GROUP INC 02/11/2025 2.16 M $4.55 M   0.18% 4.95%
ROYCE & ASSOCIATES LP 02/10/2025 1.97 M $4.15 M   35.39% 4.51%
DIMENSIONAL FUND ADVISORS LP 02/13/2025 1.67 M $3.51 M   -2.96% 3.82%
GRANAHAN INVESTMENT MANAGEMENT, LLC 02/14/2025 1.62 M $3.41 M   -13.31% 3.71%
B. RILEY ASSET MANAGEMENT, LLC 02/14/2025 1.35 M $2.85 M   -12.01% 3.10%
HEARTLAND ADVISORS INC 02/12/2025 1.20 M $2.53 M   0.00% 2.75%
BOOTHBAY FUND MANAGEMENT, LLC 02/14/2025 1.15 M $2.43 M   -13.81% 2.64%
ACADIAN ASSET MANAGEMENT LLC 02/11/2025 998,793 $2.10 M   14.33% 2.29%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 919,069 $1.94 M   0.71% 2.11%
MEROS INVESTMENT MANAGEMENT, LP 02/14/2025 813,707 $1.72 M   -2.39% 1.87%
STATE STREET CORP 02/14/2025 742,605 $1.57 M   3.52% 1.70%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 709,778 $1.50 M   -1.97% 1.63%
ACUITAS INVESTMENTS, LLC 01/31/2025 491,092 $1.04 M   0.00% 1.13%
NORTHERN TRUST CORP 02/14/2025 449,017 $947,426   -0.67% 1.03%
MORGAN STANLEY 02/14/2025 278,204 $587,010   73.50% 0.64%
BARD ASSOCIATES INC 02/06/2025 267,699 $564,845   -14.31% 0.61%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 239,696 $505,759   0.00% 0.55%
GREENWOOD CAPITAL ASSOCIATES LLC 01/27/2025 216,298 $456,389   -4.24% 0.50%
BANK OF NEW YORK MELLON CORP 02/04/2025 209,548 $442,147   -8.92% 0.48%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 02/10/2025 200,032 $422,068   11.13% 0.46%
PASADENA PRIVATE WEALTH, LLC 02/03/2025 198,039 $417,862   0.00% 0.45%
GOLDMAN SACHS GROUP INC 02/11/2025 197,404 $416,522   12.53% 0.45%
PANAGORA ASSET MANAGEMENT INC 02/13/2025 164,008 $346,057   73.06% 0.38%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 139,999 $295,398   0.00% 0.32%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 02/14/2025 129,317 $272,859   -29.91% 0.30%
JPMORGAN CHASE & CO 02/12/2025 113,591 $239,676   285.04% 0.26%
WILLIAMS & NOVAK, LLC 01/23/2025 99,210 $209,333   100.00% 0.23%
GAMCO INVESTORS, INC. ET AL 02/13/2025 95,000 $200,450   100.00% 0.22%
ASSENAGON ASSET MANAGEMENT S.A. 01/14/2025 69,799 $147,276   -65.50% 0.16%
CITADEL ADVISORS LLC 02/14/2025 68,716 $144,991   -40.76% 0.16%
BNP PARIBAS ARBITRAGE, SNC 02/14/2025 66,204 $139,690   -11.35% 0.15%
JACOBS LEVY EQUITY MANAGEMENT, INC 02/14/2025 65,008 $137,167   100.00% 0.15%
GABELLI FUNDS LLC 02/13/2025 65,000 $137,150   8.33% 0.15%
BARCLAYS PLC 02/13/2025 62,162 $131,000   5.98% 0.14%
RHUMBLINE ADVISERS 01/30/2025 39,437 $83,203   1.83% 0.09%
BANK OF AMERICA CORP /DE/ 02/14/2025 38,883 $82,043   44.36% 0.09%
UBS GROUP AG 02/14/2025 37,167 $78,423   79.36% 0.09%
TWO SIGMA INVESTMENTS, LP 02/14/2025 35,817 $75,574   6.26% 0.08%
JANE STREET GROUP, LLC 02/14/2025 35,769 $75,472   55.50% 0.08%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 35,456 $74,812   100.00% 0.08%
CITIGROUP INC 02/12/2025 32,358 $68,275   7.73% 0.07%
VERITION FUND MANAGEMENT LLC 02/14/2025 32,160 $67,858   -5.45% 0.07%
TWO SIGMA ADVISERS, LP 02/14/2025 28,556 $60,253   -28.53% 0.07%
GSA CAPITAL PARTNERS LLP 02/07/2025 28,209 $60,000   155.35% 0.06%
BRIGHTON JONES LLC 03/04/2025 25,000 $52,750   -1.44% 0.06%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 02/14/2025 24,310 $51,294   4.24% 0.06%

Harvard Bioscience, Inc. institutional Ownership - FAQ's

During the previous two years, 130 institutional investors and hedge funds held shares of Harvard Bioscience, Inc.. The most heavily invested institutionals were:

MASSMUTUAL TRUST CO FSB/ADV: 0

BlackRock, Inc.: 2.98 M

PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.: 2.76 M

Harvey Partners, LLC: 2.68 M

AMH Equity Ltd: 2.5 M

VANGUARD GROUP INC: 2.16 M

70.71% of Harvard Bioscience, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 37.87 M shares in the last 24 months. This purchase volume represents approximately $22.28 M in transactions.